封面
市场调查报告书
商品编码
1458093

全球生物防腐市场规模、份额、成长分析、按产品(设备、介质)、按应用(再生医学、生物银行)- 2024-2031 年产业预测

Global Biopreservation Market Size, Share, Growth Analysis, By Product(Equipment, Media), By Application(Regenerative Medicine, Bio-banking) - Industry Forecast 2024-2031

出版日期: | 出版商: SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2022年全球生物防腐市场规模为21.8亿美元,预计将从2023年的28.0亿美元增长到2031年的205.4亿美元,在预测期内(2024-2031年)复合年增长率为28.30%。

COVID-19 大流行对生物保存市场产生了重大影响,这主要是由于製药和生物技术公司在疫苗製造方面加大了研发力度。值得注意的是,辉瑞-BioNTech、Moderna 和 Janssen 等 mRNA 疫苗由于其独特的运输和储存先决条件(从超冷到冷藏条件),需要特定的生物保存技术。因此,这场流行病将对生物保存部门产生重大影响,该部门在生殖医学、器官移植、干细胞库和基因库等各个领域都至关重要。医疗保健支出的增加、医疗设施内部样本储存的采用以及研发投资的增加推动了市场扩张。再生医学中组织和细胞保存需求的激增吸引了专注于生物保存的製药实体增加资金,X-Therma Inc. 的 1300 万美元 A 轮融资和 Ori Biotech 的 1 亿美元 B 轮融资就是例证。在技​​术进步、产品批准和行业内战略联盟的支持下,企业和製药公司对支持生物保存公司的兴趣预计将进一步推动市场成长。英国盖伊和圣托马斯的卵巢组织冷冻生育力保存服务等措施凸显了该领域持续的技术进步,以及生物保存工具的成本效益,预示着市场扩张的光明前景。儘管如此,仪器成本、维护费用和保存过程中潜在的组织损伤等挑战可能会对市场成长构成障碍。

目录

执行摘要

  • 市场概况
  • 命运之轮

研究方法论

  • 资讯采购
  • 二手和主要资料来源
  • 市场规模估计
  • 市场假设与限制

母公司市场分析

  • 市场概况
  • 市场规模
  • 市场动态
    • 司机
    • 机会
    • 限制
    • 挑战

主要市场洞察

  • 技术分析
  • 定价分析
  • 供应链分析
  • 价值链分析
  • 市场生态系统
  • 智慧财产权分析
  • 贸易分析
  • 启动分析
  • 原料分析
  • 创新矩阵
  • 管道产品分析
  • 总体经济指标
  • 顶级投资分析
  • 成功的关键因素
  • 竞争程度

市场动态与展望

  • 市场动态
    • 司机
    • 机会
    • 限制
    • 挑战
  • 监管环境
  • 波特分析
  • 对未来颠覆的特别见解

按产品分類的全球生物防腐市场

  • 市场概况
  • 装置
  • 媒体
  • 实验室资讯管理系统(LIMS)

按应用分類的全球生物防腐市场

  • 市场概况
  • 再生医学
  • 生物银行
  • 和药物发现

全球生物防腐市场规模(按地区)

  • 市场概况
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 拉丁美洲其他地区
  • 中东和非洲 (MEA)
    • 海湾合作委员会国家
    • 南非
    • MEA 的其余部分

竞争格局

  • 前 5 名玩家比较
  • 2021 年关键参与者的市场定位
  • 主要市场参与者所采取的策略
  • 最佳制胜策略
  • 近期市集活动
  • 主要公司市占率(%),2021年

主要公司简介

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • BioLife Solutions, Inc.
  • GE Healthcare
  • VWR International LLC
  • Custom Biogenic Systems, Inc.
  • Chart Industries, Inc.
  • BioCision LLC
  • STEMCELL Technologies Inc.
  • Cesca Therapeutics Inc.
  • Core Dynamics Ltd.
  • Panasonic Healthcare Co., Ltd.
  • Avantor, Inc.
  • Lonza Group Ltd.
  • Brooks Automation, Inc.
  • BioStorage Technologies, Inc.
  • LabVantage Solutions, Inc.
  • Atlanta Biologicals, Inc.
  • Hamilton Company
  • So-Low Environmental Equipment Co.
简介目录
Product Code: SQMIG35I2223

Global Biopreservation Market size was valued at USD 2.18 billion in 2022 and is poised to grow from USD 2.80 billion in 2023 to USD 20.54 billion by 2031, growing at a CAGR of 28.30% during the forecast period (2024-2031).

The COVID-19 pandemic significantly impacted the biopreservation market, primarily due to heightened research and development efforts by pharmaceutical and biotech firms in crafting vaccines. Notably, mRNA vaccines such as Pfizer-BioNTech, Moderna, and Janssen necessitated specific biopreservation techniques owing to their distinct shipping and storage prerequisites, ranging from ultra-cold to refrigerated conditions. Consequently, the pandemic's influence is poised to be substantial on the biopreservation sector, which holds vital importance in various domains like reproductive medicine, organ transplantation, stem cell banking, and gene banking. Market expansion is fueled by escalated healthcare spending, the uptake of in-house sample storage in medical facilities, and amplified investments in research and development. The surge in demand for tissue and cell preservation in regenerative medicine has attracted augmented funding for biopreservation-focused pharmaceutical entities, exemplified by X-Therma Inc.'s USD 13 million Series A funding and Ori Biotech's USD 100 million Series B funding. Entrepreneurial and pharmaceutical interest in backing biopreservation firms is expected to further propel market growth, supported by technological advancements, product approvals, and strategic alliances within the industry. Initiatives like Guy's and St Thomas' fertility preservation service for ovarian tissue cryopreservation in the UK underscore the ongoing technological strides in the field, alongside the cost-efficiency of biopreservation tools, heralding promising prospects for market expansion. Nonetheless, challenges such as instrument costs, maintenance expenses, and potential tissue damage during preservation could pose obstacles to market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biopreservation Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biopreservation Market Segmental Analysis

The global biopreservation market is segmented based on product, application, and region. In terms of product, the market is segmented into equipment, media, and laboratory information management system (LIMS). Based on application, the market is segmented into regenerative medicine, bio-banking, drug discovery. Regionwise, the global biopreservation market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Biopreservation Market

The increasing emphasis on personalized medicine and tailored treatments has heightened the need for biopreservation solutions, essential for safeguarding biological samples such as cells, tissues, and organs, serving critical roles in research, diagnosis, and therapeutic endeavors.

Restraints in the Global Biopreservation Market

Biopreservation technologies and services often come with a hefty price tag, especially when considering long-term storage and extensive biobanking endeavors. The significant expenses involved in acquiring equipment, managing maintenance, and meeting operational demands can serve as a barrier, constraining the widespread implementation of biopreservation solutions, particularly in areas with limited resources.

Market Trends of the Global Biopreservation Market

The biopreservation market experiences a notable uptick in demand primarily fueled by the growing interest in cell-based treatments like stem cell and CAR-T cell therapies. The preservation of cell viability and functionality throughout storage and transportation is pivotal, accentuating the necessity for enhanced biopreservation methods and remedies.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Biopreservation Market by Product

  • Market Overview
  • Equipment
  • Media
  • and Laboratory Information Management System (LIMS)

Global Biopreservation Market by Application

  • Market Overview
  • Regenerative Medicine
  • Bio-banking
  • and Drug Discovery

Global Biopreservation Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Thermo Fisher Scientific Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioLife Solutions, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GE Healthcare
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • VWR International LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Custom Biogenic Systems, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Chart Industries, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioCision LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • STEMCELL Technologies Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cesca Therapeutics Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Core Dynamics Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Panasonic Healthcare Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Avantor, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lonza Group Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Brooks Automation, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioStorage Technologies, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LabVantage Solutions, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Atlanta Biologicals, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hamilton Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • So-Low Environmental Equipment Co.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments